Latest News
Newsletter
|
28 Aug 2023
August 2023 newsletter
Recent updates and upcoming events surrounding SEMA and our partners in our collective mission to revolutionize sexual reproductive health (SRH) markets.
Newsletter
|
16 Jun 2023
June Newsletter
Recent updates and upcoming events surrounding SEMA and our partners in our collective mission to revolutionize sexual reproductive health (SRH) markets.
Latest News
|
14 Jun 2023
Data partnership with Maisha Meds
Private sector channels account for over 50% of the delivery of health services in Africa, including SRH products.
Blog
Empowering Women: Reflecting on the 2023 Women Deliver Conference in Kigali, Rwanda
|
28 Jul 2023
Empowering Women: Reflecting on the 2023 Women Deliver Conference in Kigali, Rwanda
By Evelyne Wangui, Communications Associate, SEMA
Blog
|
16 Jun 2023
Exploring new private market data sources to understand sexual and reproductive health markets and drive action
By Alexis Heaton, Head of Data & Analytics, SEMA
Events
Webinar
Unlocking insights: Harnessing private sector data to enhance SRH market understanding
The objective of the event is to share what has been learned about the challenges that limit access and use of data from private sector markets for SRH products, identify potential opportunities to address these, and provide updates on progress in filling gaps and developing longer-term solutions.
Date: Thursday 28th September 2023
Time: 17:00-18:00 (Nairobi time)
Sign-up to our newsletter or follow us on social media to stay up to date.
Past Events
14–17 November 2022
SEMA at ICFP 2022
Under the theme “Family Planning & Universal Health Coverage: Innovate. Collaborate.
17–20 July 2023
SEMA at Women Deliver 2023
Our goal is to collaborate with various stakeholders, share our country and product assessments, and inspire them to organize and align efforts to drive market access.
13 July 2023
SEMA webinar on SRH product assessments: IUD, injectables, and medical abortion
Our webinar discussed SEMA's recent product assessment findings on Hormonal IUD, injectables, and medical abortion - three critical SRH products.